News | May 8, 2026
A recent study by Tatyana Avilova, Economist at Secretariat has been selected by the Editor of JAMA Health Forum as an Editor’s Choice: Clinical Trial of 2025.
Managing Director Matt Farber provided trial testimony on behalf of SVV in patent litigation involving the infringement of patents covering optical film.
Secretariat was retained by Katz PLLC on behalf of SVV in patent litigation alleging monitors sold by various companies, including Acer, infringed patents covering an optical film. Dr. Farber and Katz PLLC worked with Caldwell Cassady & Curry in the trial phase of the matter. At the conclusion of the trial, the Western District of Texas jury found the asserted patent claims to be valid and infringed, and that Acer owed SVV $10,306,900 in damages, an amount based on Dr. Farber’s opinions.
Dr. Farber submitted an extensive report in October and testified at trial to his analysis and opinions regarding a reasonable royalty. Dr. Farber’s work was supported by Matt Fitzgerald, Alex Gisquet, and Jack Schwartz.
The patents involved are U.S. Patent Nos. 10,838,135; 8,740,397; 10,797,191; and 10,868,205. The case is SVV Technology Innovations Inc. v. Acer Inc., case number 6:22-cv-00640, in the U.S. District Court for the Western District of Texas.
Law360 and Bloomberg Law (subscriptions may be required) coverage may be found here and here.
Related: “SVV Technologies Awarded $22.4 Million in Another Patent Infringement Verdict”